These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 20827761

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Generation and Characterization of Monoclonal Antibodies against a Cyclic Variant of Hepatitis C Virus E2 Epitope 412-422.
    Sandomenico A, Leonardi A, Berisio R, Sanguigno L, Focà G, Focà A, Ruggiero A, Doti N, Muscariello L, Barone D, Farina C, Owsianka A, Vitagliano L, Patel AH, Ruvo M.
    J Virol; 2016 Jan 27; 90(7):3745-59. PubMed ID: 26819303
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. High-resolution epitope mapping for monoclonal antibodies to the structural protein Erns of classical swine fever virus using peptide array and random peptide phage display approaches.
    Lin M, McRae H, Dan H, Tangorra E, Laverdiere A, Pasick J.
    J Gen Virol; 2010 Dec 27; 91(Pt 12):2928-40. PubMed ID: 20810747
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Expression, immunogenicity and diagnostic value of envelope proteins from an Egyptian hepatitis C virus isolate.
    Shawky H, Maghraby AS, Solliman Mel-D, El-Mokadem MT, Sherif MM, Arafa A, Bahgat MM.
    Arch Virol; 2015 Apr 27; 160(4):945-58. PubMed ID: 25631616
    [Abstract] [Full Text] [Related]

  • 28. Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries.
    Bugli F, Mancini N, Kang CY, Di Campli C, Grieco A, Manzin A, Gabrielli A, Gasbarrini A, Fadda G, Varaldo PE, Clementi M, Burioni R.
    J Virol; 2001 Oct 27; 75(20):9986-90. PubMed ID: 11559832
    [Abstract] [Full Text] [Related]

  • 29. Murine antibody against E2 can capture hepatitis C virus in vitro.
    Ma W, Feng B, Tao Q.
    Chin Med J (Engl); 2001 Aug 27; 114(8):860-3. PubMed ID: 11780368
    [Abstract] [Full Text] [Related]

  • 30. Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.
    Burioni R, Bugli F, Mancini N, Rosa D, Di Campli C, Moroncini G, Manzin A, Abrignani S, Varaldo PE, Clementi M, Fadda G.
    Virology; 2001 Sep 15; 288(1):29-35. PubMed ID: 11543655
    [Abstract] [Full Text] [Related]

  • 31. Mimotope vaccination for epitope-specific induction of anti-CD20 antibodies.
    Li M, Yan Z, Han W, Zhang Y.
    Cell Immunol; 2006 Feb 15; 239(2):136-43. PubMed ID: 16814270
    [Abstract] [Full Text] [Related]

  • 32. Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity.
    Olszewska W, Obeid OE, Steward MW.
    Virology; 2000 Jun 20; 272(1):98-105. PubMed ID: 10873752
    [Abstract] [Full Text] [Related]

  • 33. Identification of a conserved linear B-cell epitope at the N-terminus of the E2 glycoprotein of Classical swine fever virus by phage-displayed random peptide library.
    Peng WP, Hou Q, Xia ZH, Chen D, Li N, Sun Y, Qiu HJ.
    Virus Res; 2008 Aug 20; 135(2):267-72. PubMed ID: 18485511
    [Abstract] [Full Text] [Related]

  • 34. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia.
    Lechmann M, Ihlenfeldt HG, Braunschweiger I, Giers G, Jung G, Matz B, Kaiser R, Sauerbruch T, Spengler U.
    Hepatology; 1996 Oct 20; 24(4):790-5. PubMed ID: 8855177
    [Abstract] [Full Text] [Related]

  • 35. Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines.
    Siler CA, McGettigan JP, Dietzschold B, Herrine SK, Dubuisson J, Pomerantz RJ, Schnell MJ.
    Virology; 2002 Jan 05; 292(1):24-34. PubMed ID: 11878905
    [Abstract] [Full Text] [Related]

  • 36. Modulation of immune responses to hepatitis C virus envelope E2 protein following injection of plasmid DNA using single or combined delivery routes.
    Fournillier A, Nakano I, Vitvitski L, Depla E, Vidalin O, Maertens G, Trépo C, Inchauspé G.
    Hepatology; 1998 Jul 05; 28(1):237-44. PubMed ID: 9657118
    [Abstract] [Full Text] [Related]

  • 37. Selection of antigenic and immunogenic mimics of hepatitis C virus using sera from patients.
    Prezzi C, Nuzzo M, Meola A, Delmastro P, Galfrè G, Cortese R, Nicosia A, Monaci P.
    J Immunol; 1996 Jun 01; 156(11):4504-13. PubMed ID: 8666827
    [Abstract] [Full Text] [Related]

  • 38. Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection.
    Burioni R, Mancini N, Carletti S, Perotti M, Grieco A, Canducci F, Varaldo PE, Clementi M.
    Virology; 2004 Oct 01; 327(2):242-8. PubMed ID: 15351212
    [Abstract] [Full Text] [Related]

  • 39. The development of a mimotope-based synthetic peptide vaccine against respiratory syncytial virus.
    Steward MW.
    Biologicals; 2001 Oct 01; 29(3-4):215-9. PubMed ID: 11851318
    [Abstract] [Full Text] [Related]

  • 40. Systematic analysis of attenuated Coxsackievirus expressing a foreign gene as a viral vaccine vector.
    Kim DS, Cho YJ, Kim BG, Lee SH, Nam JH.
    Vaccine; 2010 Feb 03; 28(5):1234-40. PubMed ID: 19941986
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.